Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil - O’Reilly, SE; Gelmon, KA; Onetto, N (J Clin Oncol, 1993)